AMN HEALTHCARE SERVICES INC
No SEC Form 4 filings for $AMN in the last 30 days.
Simply Wall St reports AMN Healthcare Services (AMN) swung from a loss to profit in Q2 2026 and posted higher sales, alongside updated Q3 revenue guidance. The stock fell 6.1% in one day and 11.26% over a week, though it is up 103.7% YTD. It cites fair value $31.86 vs $30.80 close and P/S 0.3x.
AMN Healthcare Services (NYSE:AMN) reported Q2 CY2026 revenue of $673.2 million, up 2.3% year on year, beating Wall Street expectations. Next-quarter revenue guidance was $647.5 million at the midpoint, about 4.7% above consensus. Non-GAAP EPS was $0.77, above estimates, and the stock rose 11.5% to $34.29. Analysts expect full-year EPS to fall to $0.88.
AMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.
Over the past 7 days, alphai's AI scored 4 news stories mentioning AMN (AMN HEALTHCARE SERVICES INC). Coverage has skewed bullish: 3 bullish, 1 neutral, and 0 bearish.
Recent AMN coverage spans financial news, earnings and market movers.
The earnings rebound and new Q3 guidance are the core catalysts, but the article frames valuation as the key debate after a sharp run and recent pullback.
Results and upside revenue guidance likely support near-term momentum, but forward EPS expectations imply a sharp full-year earnings decline.
Results beat guidance with improved margins and higher adjusted EBITDA, while cash flow remains pressured by client deposit returns tied to prior-quarter labor disruption.
This is an earnings preview with consensus expectations and peer read-through, so the main trade is positioning around the upcoming print versus the 4.5% YoY revenue decline expectation.
The move is framed as a read-across to digital healthcare staffing and AI matching, not as a direct AMN-specific fundamental update.
alphai scores every news story that mentions AMN with an AI model for sentiment and relevance, and aggregates insider trades from AMN HEALTHCARE SERVICES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
Simply Wall St reports AMN Healthcare Services (AMN) swung from a loss to profit in Q2 2026 and posted higher sales, alongside updated Q3 revenue guidance. The stock fell 6.1% in one day and 11.26% over a week, though it is up 103.7% YTD. It cites fair value $31.86 vs $30.80 close and P/S 0.3x.
6 min readAMN Healthcare Services (NYSE:AMN) reported Q2 CY2026 revenue of $673.2 million, up 2.3% year on year, beating Wall Street expectations. Next-quarter revenue guidance was $647.5 million at the midpoint, about 4.7% above consensus. Non-GAAP EPS was $0.77, above estimates, and the stock rose 11.5% to $34.29. Analysts expect full-year EPS to fall to $0.88.
4 min readAMN Healthcare Services (NYSE: AMN) reported Q2 2026 revenue of $673 million, up 2% year over year, and adjusted EBITDA of $73 million. GAAP net income was $21 million, or $0.53/share, and adjusted EPS was $0.77. The company said results exceeded guidance, citing travel nurse and allied growth, 27% search revenue growth, and acquisitions expanding AI and leadership offerings. Q3 revenue is expected 1-3% higher.
6 min readAMN Healthcare Services (NYSE: AMN) is set to report Q2 results Thursday after market close. The article notes last quarter’s revenue of $1.38B, up 99.9% year over year, and a revenue/EPS beat. For this quarter, analysts expect revenue down 4.5% y/y. The average analyst price target is $31.86 versus a $33.24 share price.
3 min readAMN Healthcare Services shares (NYSE: AMN) rose about 6.4% in the afternoon after Ardian acquired a majority stake in Pflegia, a healthcare staffing AI platform. The article says Pflegia has 900,000+ registered candidates and 10,000+ care providers, and plans international expansion and AI upgrades. It also cites Citizens reiterating a Market Outperform rating and a $36 price target.
4 min readAMN Healthcare reported a strong Q1 2026 with revenue doubling to $1.378 billion, significantly driven by $722 million from labor disruption events. While net income and adjusted diluted EPS saw substantial increases, the company's Q2 2026 guidance suggests a cooling period with much lower revenue expectations, indicating a high reliance on non-recurring disruption events for its Q1 performance. AMN Healthcare maintains a strong cash position and manageable debt despite the anticipated step-down in the next quarter.
3 min readAMN Healthcare Services, Inc. reported strong first-quarter 2026 financial results, exceeding guidance with quarterly revenue of $1.378 billion and adjusted EBITDA of $166 million. The company achieved GAAP diluted EPS of $1.59 and adjusted diluted EPS of $2.10, showing significant year-over-year growth. This performance was driven by increased travel nursing volume, allied health, international nurse staffing, and search businesses, along with substantial revenue from labor disruption events.
3 min readThis document is an earnings call transcript for AMN Healthcare Services, Inc. (NYSE:AMN) for the fourth quarter of 2025. It details the discussions held during the company's investor call regarding its financial performance and outlook.
5 min readAMN Healthcare beats third-quarter 2025 earnings and revenue estimates despite lower margins and year-over-year declines across key segments.
2 min readThe headline numbers for AMN Healthcare (AMN) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
3 min read
